Publications

Guidelines for cellular and molecular pathology content in clinical trial protocols published

The SPIRIT-Path guidelines for the inclusion of pathology in clinical trial protocols have been published in The Lancet Oncology. Prof Anna DeFazio, Chair TR-ANZGOG Steering Committee The SPIRIT-Path extension guidelines were developed [...]

Guidelines for cellular and molecular pathology content in clinical trial protocols published2021-10-07T05:58:12+11:00

Dr Rachel Campbell discusses findings from a new publication for the MOST-S26 study

A new journal has been published by the National Library of Medicine for ANZGOG's MOST-S26 study. The Measure of Ovarian Symptoms and Treatment study (MOST-S26) detected an improvement in symptoms of peripheral neuropathy, psychological [...]

Dr Rachel Campbell discusses findings from a new publication for the MOST-S26 study2021-09-15T00:55:56+10:00

Principle Investigator of WHAM study, Professor Martha Hickey, shares study findings

WHAM (What Happens After Menopause?) was a multicentre prospective study investigating the impact of risk reducing bilateral salpingo-oophorectomy on non-cancer outcomes in young high-risk women. The ANZGOG supported study assessed the relationship between surgical menopause and [...]

Principle Investigator of WHAM study, Professor Martha Hickey, shares study findings2021-07-28T07:03:34+10:00

Assoc Prof Alison Brand AM speaks to ABC Radio about a recent New England Journal of Medicine paper

Assoc Prof Alison Brand AM spoke to Dr Norman Swan - the host of ABC Radio’s program Health Report - commenting on a recent paper in the New England Journal of Medicine about gene sequencing and [...]

Assoc Prof Alison Brand AM speaks to ABC Radio about a recent New England Journal of Medicine paper2021-03-01T05:08:29+11:00

Dr Tharani Sivakumaran shares the findings of her ovarian cancer study publication

ANZGOG Member, Dr Tharani Sivakumaran, comments on the findings of a recent publication of an ovarian cancer study that looks into the impact of chemotherapy dose reductions and dose delays on progression-free survival (PFS) in women [...]

Dr Tharani Sivakumaran shares the findings of her ovarian cancer study publication2020-10-07T03:37:48+11:00
Go to Top